Prudential Financial Inc Sangamo Therapeutics, Inc Transaction History

Prudential Financial Inc

  • $70.8 Billion
  • Q4 2024

A detailed history of Prudential Financial Inc transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Prudential Financial Inc holds 11,343 shares of SGMO stock, worth $13,157. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,343
Holding current value
$13,157
% of portfolio
0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$0.78 - $2.87 $8,847 - $32,554
11,343 New
11,343 $11,000
Q1 2024

May 14, 2024
BUY
$0.42 - $1.38 $1,554 - $5,106
3,700 Added 4.09%
94,236 $63,000
Q4 2023

Feb 13, 2024
SELL
$0.3 - $0.63 $54,000 - $113,400
-180,000 Reduced 66.53%
90,536 $48,000
Q3 2023

Nov 13, 2023
SELL
$0.58 - $1.47 $67,512 - $171,108
-116,400 Reduced 30.08%
270,536 $162,000
Q2 2023

Aug 11, 2023
BUY
$1.11 - $1.74 $248,029 - $388,803
223,450 Added 136.68%
386,936 $503,000
Q1 2023

May 12, 2023
BUY
$1.66 - $3.67 $271,386 - $599,993
163,486 New
163,486 $287,000
Q4 2021

Feb 14, 2022
SELL
$7.29 - $10.97 $105,413 - $158,626
-14,460 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$9.01 - $12.01 $29,904 - $39,861
3,319 Added 29.79%
14,460 $130,000
Q2 2021

Aug 16, 2021
BUY
$10.17 - $12.64 $113,303 - $140,822
11,141 New
11,141 $133,000
Q1 2021

May 12, 2021
SELL
$10.88 - $17.05 $114,686 - $179,724
-10,541 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$9.23 - $18.18 $6,045 - $11,907
-655 Reduced 5.85%
10,541 $164,000
Q3 2020

Nov 16, 2020
SELL
$9.38 - $12.48 $3,198 - $4,255
-341 Reduced 2.96%
11,196 $106,000
Q2 2020

Aug 12, 2020
BUY
$6.21 - $11.83 $1,925 - $3,667
310 Added 2.76%
11,537 $103,000
Q1 2020

May 12, 2020
SELL
$5.05 - $8.85 $4,777 - $8,372
-946 Reduced 7.77%
11,227 $71,000
Q4 2019

Feb 11, 2020
BUY
$8.03 - $11.7 $1,622 - $2,363
202 Added 1.69%
12,173 $101,000
Q3 2019

Nov 13, 2019
SELL
$9.05 - $12.22 $17,258 - $23,303
-1,907 Reduced 13.74%
11,971 $108,000
Q2 2019

Aug 08, 2019
BUY
$8.75 - $13.03 $11,112 - $16,548
1,270 Added 10.07%
13,878 $0
Q1 2019

May 15, 2019
BUY
$7.72 - $12.81 $15,301 - $25,389
1,982 Added 18.65%
12,608 $0
Q4 2018

Feb 07, 2019
SELL
$9.51 - $16.6 $1,141 - $1,992
-120 Reduced 1.12%
10,626 $121,000
Q3 2018

Nov 07, 2018
BUY
$13.05 - $19.05 $1,305 - $1,905
100 Added 0.94%
10,746 $0
Q2 2018

Aug 13, 2018
SELL
$13.9 - $19.8 $6.88 Million - $9.8 Million
-494,890 Reduced 97.89%
10,646 $0
Q1 2018

May 04, 2018
BUY
$16.7 - $26.35 $6.49 Million - $10.2 Million
388,480 Added 331.88%
505,536 $0
Q4 2017

Feb 13, 2018
BUY
$11.6 - $17.35 $1.36 Million - $2.03 Million
117,056
117,056 $1.92 Million

Others Institutions Holding SGMO

# of Institutions
113
Shares Held
57.8M
Call Options Held
576K
Put Options Held
1.17M
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $182M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email